Disorders of the Respiratory System

102 Disorders of the Respiratory System



Advancements in the treatment of respiratory distress in newborns have significantly reduced infant mortality in the United States over the span of 40 years. Neonatal morbidity persists despite major progress and includes maternal–infant separation caused by prolonged hospitalizations and need for specialized hospital care, multiple diagnostic studies, advanced respiratory support, and an increased likelihood of developing chronic lung disease. In addition, respiratory distress in newborns remains a significant cause of neonatal morbidity and mortality in the developing world.



Etiology and Pathogenesis


Several well-defined events are necessary for the transition to extrauterine life, including establishment of spontaneous respirations, clearance of amniotic fluid from the airway, surfactant release and function, and a decrease in pulmonary vascular resistance to aid in pulmonary blood flow. Impediments to one or more of these events generally manifest as respiratory distress in the newborn. The differential diagnosis of respiratory distress in neonates is broad, and nonrespiratory etiologies are varied (Table 102-1).


Table 102-1 Differential Diagnosis of Neonatal Respiratory Distress























System Category Diagnoses
Respiratory























Cardiac












Neurologic  







Metabolic  




Respiratory Distress Syndrome


Respiratory distress syndrome (RDS), also known as hyaline membrane disease, is the end result of a relative surfactant deficiency that, when combined with the compliant chest wall of the neonate, promotes alveolar atelectasis and prevents newborns from developing a normal functional residual capacity (Figure 102-1). The most significant risk factor for RDS is prematurity because surfactant production begins between 24 and 28 weeks of gestation and does not become fully functional until at least 35 weeks. Other risk factors for the development of RDS include maternal diabetes; early-onset sepsis; and less commonly, congenital surfactant deficiency. Fifty percent of infants with birth weights between 500 and 1500 g develop some degree of respiratory distress; however, survival is greater than 90% with the use of exogenous surfactant and antenatal steroids.




Transient Tachypnea of the Newborn


Transient tachypnea of the newborn (TTN) is one of the most common respiratory disorders of newborns with an incidence of 5.7 per 1000 deliveries. TTN occurs as a result of delayed reabsorption and clearance of fetal alveolar fluid from the airways. Throughout gestation, epithelial cells in the lung secrete alveolar fluid. In the late gestational period, epithelial ion channels shift from active secretion of sodium and chloride to active reabsorption caused by high circulating levels of maternal epinephrine. At birth, inspired oxygen increases gene expression of the sodium transporter, which further facilitates fluid shifts from the airways to the interstitium and intravascular space. Passive fluid reabsorption is also postulated to play a role. However, the accumulation of fluid in the interstitium can decrease lung compliance and prevent the establishment of functional residual capacity.


Factors that increase the likelihood of TTN include nonreassuring fetal status, instrumentation at delivery, Apgar score less than 7 at 1 minute, male sex, in vitro fertilization, multiple gestation, and macrosomia. Relevant maternal characteristics include history of maternal asthma, maternal diabetes, and nulliparity. Cesarean section poses a theoretical risk because of the absence of a “squeeze” effect created by passage through the vagina, which may increase the passive absorption of alveolar fluid. The risk of TTN in the setting of cesarean section increases with absence of labor before delivery and with delivery before 39 weeks.

< div class='tao-gold-member'>

Stay updated, free articles. Join our Telegram channel

Jun 19, 2016 | Posted by in PEDIATRICS | Comments Off on Disorders of the Respiratory System

Full access? Get Clinical Tree

Get Clinical Tree app for offline access